Explore Your Local Site

Looks like you've landed on our   site. Let's take you home:    

Please note that the content and products on the    site might not be available in your region.

 

Choose the language:

  Homepage
Continue on the current website:  

 

CINA-LVO

CINA - LVO application analyses CT angiography of the head (CTA) images, flags and communicates suspected positive findings of Large Vessel Occlusion (LVO) of the anterior circulation (distal ICA, MCA-M1 or proximal MCA-M2).1

Inquire Now

Avicenna
  • Large Vessel Occlusion
  • CT
  • Head
  • Contrast
  • Triage

A.I. Powered Large Vessel Occulusion triage application

CINA image processing applications provide a case level notification in case of suspected positive findings. This notification can be used by the 3rd party platform to flag series in the platform's worklist to assist trained radiologists in workflow triage by flagging and communicating suspected positive findings of large vessel occlusion (LVO).1

yellow arrow

>90% overall performance (Sensitivity & Specificity)1

 

    Automated Detection of Suspected LVO

    Automated Detection & Alert of Suspected Large Vessel Occlusion

    The device is intended to assist hospital networks and trained radiologists in workflow triage by flagging and communicating suspected positive findings of CT angiographies of the head for large vessel occlusion (LVO).1

    Highlights cases with suspected LVO

    Analyse images and highlights cases with suspected Large Vessel Occlusion

    The CINA-LVO triage application's mean "time-to­ notification" is estimated to be 34.7 seconds.1

    References

    References

    1. CINA User Guide AV-DP-CINA-10 013-SUM-USER-BF-V04-EN-OUS

    What customers are saying

    In a busy practice, radiologists are expected to interpret exams quickly and accurately. The Avicenna software solution provides an Al-assisted preliminary review of all exams, helping to prioritize patients with positive findings and optimize our clinical workflow. In addition, the extra "set of eyes" provided by the Al software improves our overall confidence and efficiency."

    Daniel Chow
    Radiologist and Director at UCI Health Center for Al in Diagnostic Medicine

    May not reflect a typical user experience; actual results may vary.
    Dr. Daniel Chow has a financial interest in this app vendor

    Request a demo

    See Ahead for Yourself

    Inquire now

    The clinical apps supplied on Calantic marketplace are from third parties and not manufactured or sponsored by Bayer or its affiliates. 

    Bayer reserves the right to modify the specifications and features described herein or to discontinue any product or service identified in this publication at any time without prior notice or obligation. Please contact your authorised Bayer representative for the most current information.

    © 2024 Bayer. This material may not be reproduced, displayed, modified or distributed without the express prior written consent of Bayer.

    For Medical Information inquiries about Calantic, please contact medinfo.anz@bayer.com or 1800 008 757 (AU).

    For medical inquiries relating to devices please contact your local Bayer representative.

     

    Report Adverse Events

    If you want to report an adverse event for medicines or devices, please contact your healthcare professional (e.g. physician or pharmacist) or the Therapeutic Goods Administration (TGA). Details on how to report to the TGA can be found at https://www.tga.gov.au/reporting-problems

    Adverse events for devices should also be reported to Bayer via email to ricustomercomplaints@bayer.com

     

    If you want to report a Quality Complaint

    If you want to report a device quality complaint please contact ricustomercomplaints@bayer.com

     

    Radiology

    Bayer Australia Ltd

    875 Pacific Highway, Pymble NSW 2073

    ABN 22 000 138 714

     

    © 2024 Bayer Pharmaceuticals

    The clinical apps supplied on Calantic marketplace are from third parties and not manufactured or sponsored Bayer or its affiliates. 

    Bayer reserves the right to modify the specifications and features described herein or to discontinue any product or service identified in this publication at any time without prior notice or obligation. Please contact your authorised Bayer representative for the most current information.

    © 2024 Bayer. This material may not be reproduced,displayed, modified or distributed without the express prior written consent of Bayer.

    For Medical Information relating to medicines please contact our Medical department at medinfo.anz@bayer.com or on 1800 008 757 (AU).

    For medical inquiries relating to devices please contact your local Bayer representative.

     

    Report Adverse Events

    If you want to report an adverse event for medicines or devices, please contact your healthcare professional (e.g. physician or pharmacist) or the Therapeutic Goods Administration (TGA). Details on how to report to the TGA can be found at https://www.tga.gov.au/reporting-problems

    Adverse events for medicines should also be reported to Bayer via email to drugsafety.anz@bayer.com or by phoning 1800 008 757.

    Adverse events for devices should also be reported to Bayer via email to ricustomercomplaints@bayer.com

     

    If you want to report a Quality Complaint

    If you want to report a medicine quality complaint please contact drugsafety.anz@bayer.com

    If you want to report a device quality complaint please contact ricustomercomplaints@bayer.com

     

    Radiology

    Bayer Australia Ltd

    875 Pacific Highway, Pymble NSW 2073

    ABN 22 000 138 714

     

    PP-CALA-AU-0012-2

    Date of preparation: July 2024

    Bayer Logo